AdCLD-CoV19-1

BIOLOGICAL2 trials

Sponsors

Cellid Co., Ltd.

Conditions

COVID-19Covid19Vaccines

Phase 1

Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers

CompletedNCT05047692

Cellid Co., Ltd.Covid19

Start: 2021-09-09End: 2023-06-21Updated: 2023-07-28

Phase 2

Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1

TerminatedNCT05520970

Cellid Co., Ltd.COVID-19, Vaccines

Start: 2022-08-19End: 2022-11-08Updated: 2023-06-22